Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pecs II and Supraclavicular Block for AV Grafting
NCT02331030Completed
- Sponsor
- Changi General Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in end stage renal disease (ESRD), sponsored by Changi General Hospital. Primary endpoint: Need for intraoperative local anaesthetic supplementation. Started Dec 2014; status: completed.
02
Drugs
ropivacaine
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02331030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02331030.